{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:38:40Z","timestamp":1794346720893,"version":"4.9.0"},"reference-count":48,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":392,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,11,27]]},"abstract":"<jats:sec><jats:title>Aim:<\/jats:title><jats:p>The additive effect of ecabet sodium in combination with dual therapy on <jats:italic>Helicobacter pylori<\/jats:italic> eradication was evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p> <jats:italic>H. pylori<\/jats:italic>\u2010positive chronic gastritis patients were randomly assigned to one of the following three groups and medicated for 2\u2003weeks. Group LA: dual therapy (lansoprazole 30\u2003mg o.d. plus amoxicillin 750\u2003mg b.d.). Group LA1E: dual therapy plus ecabet sodium (1\u2003g b.d.). Group LA2E: dual therapy plus ecabet sodium (2\u2003g b.d.). Patients were evaluated 4\u2003weeks after the cessation of treatment by culture and <jats:sup>13<\/jats:sup>C\u2010urea breath test.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Seventy\u2010one patients (mean age, 56.6\u2003years; range, 26\u201379\u2003years; 40 males, 31 females) were enrolled in this prospective, single\u2010blind study, and 68 completed the protocol. The eradication rates per protocol patient were 43% in group LA, 62% in group LA1E, and 79% in group LA2E, and those on the intention\u2010to\u2010treat basis were 42% in group LA, 57% in group LA1E and 79% in group LA2E. The eradication rate in group LA2E was significantly higher than group LA (<jats:italic>P<\/jats:italic>=0.032 in per protocol, <jats:italic>P<\/jats:italic>=0.022 in intention\u2010to\u2010treat). Adverse effects were observed in 10 patients in this study. There were no severe adverse effects caused by ecabet sodium.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>High\u2010dose ecabet sodium increases eradication rates of <jats:italic>H. pylori<\/jats:italic> in dual therapy with lansoprazole and amoxicillin.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00852.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:40:11Z","timestamp":1047354011000},"page":"1523-1527","source":"Crossref","is-referenced-by-count":25,"title":["High\u2010dose ecabet sodium improves the eradication rate of <i>Helicobacter pylori<\/i> in dual therapy with lansoprazole and amoxicillin"],"prefix":"10.1111","volume":"14","author":[{"given":"H.","family":"Kagaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sukegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hokari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Asaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1273","article-title":"Unidentified curved bacilli on gastric epithelium in active chronic gastritis","author":"Warren JR","year":"1983","journal-title":"Lancet"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711540203"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1991.tb01448.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90938-D"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90929-4"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.1.19"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.52194000.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199409000-00004"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70119-8"},{"key":"e_1_2_6_13_2","unstructured":"MegraudF.Helicobacter pyloriresistance to antibiotics. In: Hunt RH Tytgat GNJ eds.Helicobacter pylori: Basic Mechanisms to Clinical Cure. Proceedings of the International Symposium 3\u20136 November 1993: pp 570\u201383."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb1978.14.547"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02064387"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.62.169"},{"key":"e_1_2_6_17_2","first-page":"494","article-title":"Roles of prostaglandins, nitric oxide and the capsaicin\u2010sensitive sensory nerves in gastroprotection produced by ecabet sodium","volume":"275","author":"Kinoshita M","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409094885"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199506002-00036"},{"key":"e_1_2_6_20_2","first-page":"59","article-title":"Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients","volume":"31","author":"Shimoyama T","year":"1996","journal-title":"J Gastroenterol"},{"key":"e_1_2_6_21_2","first-page":"36","article-title":"Clinical studies of 13C\u2010urea breath test in Japan","volume":"33","author":"Kato M","year":"1998","journal-title":"J Gastroenterol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.51.65"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.52.631"},{"key":"e_1_2_6_24_2","first-page":"546","article-title":"Effects of the new anti\u2010ulcer agent 12\u2010sulfodehydroabietic acid monosodium salt on healing of acetic acid\u2010induced gastric ulcers in rats","volume":"41","author":"Onoda Y","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018885005109"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00502.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90957-3"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.18.850"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(97)01622-1"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1295"},{"key":"e_1_2_6_31_2","first-page":"A12","article-title":"The inhibitory effect of ecabet sodium on ATPase of Helicobacter pylori","volume":"43","author":"Shibata K","year":"1998","journal-title":"Gut"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520010077036"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_6_34_2","first-page":"S1","article-title":"Proceedings of the American Digestive Health Foundation International Update Conference on Helicobacter pylori","volume":"113","author":"American Digestive Health Foundation","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091311"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00003.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80027-3"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.455_t.x"},{"key":"e_1_2_6_39_2","first-page":"386","article-title":"Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin\u2010influence on treatment outcome","volume":"93","author":"Adamek RJ","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.2.477"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.00806.x"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00350.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(98)00064-6","article-title":"Stable amoxicillin resistance Helicobacter pylori","volume":"352","author":"Van Zwet AA","year":"1998","journal-title":"Lancet"},{"key":"e_1_2_6_44_2","first-page":"595","article-title":"Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases","volume":"87","author":"Slomiany BL","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_45_2","first-page":"198S","article-title":"Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori\u2010infected gastric ulcer patients","volume":"43","author":"Kato M","year":"1998","journal-title":"Dig Dis Sci"},{"key":"e_1_2_6_46_2","first-page":"525","article-title":"Bactericidal effect of ecabet sodium on clarithromycin\u2010 and metronidazole\u2010resistant clinical isolates of Helicobacter pylori","volume":"50","author":"Shibata K","year":"1997","journal-title":"Jpn J Antibiot"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00324.x"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00692.x"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02934107"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00852.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00852.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00852.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:03:14Z","timestamp":1698566594000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00852.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,27]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11,27]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00852.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00852.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11,27]]}}}